메뉴 건너뛰기
Biology of Blood and Marrow Transplantation
Volumn 12, Issue 6, 2006, Pages 693-694
Mesenchymal Stem Cells Combined with Cyclosporine Inhibits Cytotoxic T Cells
Author keywords

[No Author keywords available]
Indexed keywords

ALLOANTIGEN; CYCLOSPORIN A; IMMUNOGLOBULIN ANTIBODY; INTERLEUKIN 2 RECEPTOR ANTIBODY; PHYTOHEMAGGLUTININ; T LYMPHOCYTE ANTIBODY;
EID: 33646798072     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2006.04.004     Document Type: Letter
Times cited : (14)
References (7)
  • 1
    • 28744436422 scopus 로고    scopus 로고
    • Human mesenchymal stem cells and cyclosporin a exert a synergistic suppressive effect on in vitro activation of alloantigen-specific cytotoxic lymphocytes
    • Maccario R., Moretta A., Cometa A., et al. Human mesenchymal stem cells and cyclosporin a exert a synergistic suppressive effect on in vitro activation of alloantigen-specific cytotoxic lymphocytes. Biol Blood Marrow Transplant 11 (2005) 1031-1032
    • (2005) Biol Blood Marrow Transplant , vol.11 , pp. 1031-1032
    • Maccario, R.1    Moretta, A.2    Cometa, A.3
  • 2
    • 0242300602 scopus 로고    scopus 로고
    • Mesenchymal stem cells inhibit the formation of cytotoxic T lymphocytes, but not activated cytotoxic T lymphocytes or natural killer cells
    • Rasmusson I., Ringden O., Sundberg B., and Le Blanc K. Mesenchymal stem cells inhibit the formation of cytotoxic T lymphocytes, but not activated cytotoxic T lymphocytes or natural killer cells. Transplantation 76 (2003) 1208-1213
    • (2003) Transplantation , vol.76 , pp. 1208-1213
    • Rasmusson, I.1    Ringden, O.2    Sundberg, B.3    Le Blanc, K.4
  • 3
    • 2342482526 scopus 로고    scopus 로고
    • Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells
    • Le Blanc K., Rasmusson I., Sundberg B., et al. Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells. Lancet 363 (2004) 1439-1441
    • (2004) Lancet , vol.363 , pp. 1439-1441
    • Le Blanc, K.1    Rasmusson, I.2    Sundberg, B.3
  • 4
    • 33744913533 scopus 로고    scopus 로고
    • Ringden O, Uzunel M, Rasmusson I, et al. Mesenchymal stem cells for treatment of therapy-resistant graft-versus-host disease. Transplantation. 2006. In press.
  • 5
    • 12944328008 scopus 로고    scopus 로고
    • Epstein-Barr virus (EBV) load in bone marrow transplant recipients at risk to develop posttransplant lymphoproliferative disease. prophylactic infusion of EBV-specific cytotoxic T cells
    • Gustafsson A., Levitsky V., Zou J.Z., et al. Epstein-Barr virus (EBV) load in bone marrow transplant recipients at risk to develop posttransplant lymphoproliferative disease. prophylactic infusion of EBV-specific cytotoxic T cells. Blood 95 (2000) 807-814
    • (2000) Blood , vol.95 , pp. 807-814
    • Gustafsson, A.1    Levitsky, V.2    Zou, J.Z.3
  • 6
    • 4344683220 scopus 로고    scopus 로고
    • Mesenchymal stem cells inhibit the expression of CD25 (interleukin-2 receptor) and CD38 on phytohaemagglutinin-activated lymphocytes
    • Le Blanc K., Rasmusson I., Gotherstrom C., et al. Mesenchymal stem cells inhibit the expression of CD25 (interleukin-2 receptor) and CD38 on phytohaemagglutinin-activated lymphocytes. Scand J Immunol 60 (2004) 307-315
    • (2004) Scand J Immunol , vol.60 , pp. 307-315
    • Le Blanc, K.1    Rasmusson, I.2    Gotherstrom, C.3
  • 7
    • 15044348816 scopus 로고    scopus 로고
    • Mesenchymal stem cells inhibit lymphocyte proliferation by mitogens and alloantigens by different mechanisms
    • Rasmusson I., Ringden O., Sundberg B., and Le Blanc K. Mesenchymal stem cells inhibit lymphocyte proliferation by mitogens and alloantigens by different mechanisms. Exp Cell Res 305 (2005) 33-41
    • (2005) Exp Cell Res , vol.305 , pp. 33-41
    • Rasmusson, I.1    Ringden, O.2    Sundberg, B.3    Le Blanc, K.4

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.